Related Experiment Video
Updated: May 4, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Factors associated with early platelet activation in obese children
Anel Gómez García1, Guillermina García Núñez2, Martha Eva Viveros Sandoval3
1Biomedical Research Center of Michoacán, Mexican Institute of Social Security, Morelia, Michoacán, México. anel_gomez04@yahoo.com.mx anel.gomez@imss.gob.mx.
Insights
Obese children show increased platelet activation, linked to higher levels of leptin, von Willebrand Factor (vWF), uric acid (UA), and lower high-density lipoprotein (HDL). These factors may indicate early cardiovascular risk in pediatric obesity.
Area of Science:
- Pediatric Endocrinology
- Hematology
- Cardiovascular Research
Background:
- Childhood obesity is a growing global health concern.
- Obesity is associated with increased risk of cardiovascular disease.
- Platelet activation plays a role in atherothrombosis.
Purpose of the Study:
- To investigate factors associated with platelet activation in obese children.
- To identify predictors of platelet activation in pediatric obesity.
Main Methods:
- Cross-sectional study involving 79 obese and 64 non-obese children (ages 5-10).
- Assessed platelet activation via soluble P-selectin (sP-selectin).
- Measured leptin, uric acid (UA), von Willebrand Factor (vWF), PAI-1, lipid profile, and glucose.
Main Results:
- Obese children had higher plasma sP-selectin, leptin, PAI-1, and vWF.
- Leptin, vWF, UA, and HDL were associated with platelet activation.
- Leptin, vWF, UA, and HDL were the best predictors of platelet activation, adjusted for age and sex.
Conclusions:
- Obese children exhibit heightened risk for early platelet activation.
- Leptin, vWF, UA, and HDL are key factors linked to platelet activation in obese children.
- Further research is needed to elucidate mechanisms and long-term cardiovascular implications.
Objective:
To investigate the factors associated with platelet activation in obese children.
Design:
Cross-sectional study.
Setting:
Department of Pediatrics of Regional Hospital N∘ 1 of Mexican Institute of Social Security in Morelia, Michoacán, Mexico.
Participants:
79 obese and 64 non-obese children between the ages of 5 and 10 years.
Main Outcomes Measures:
Obese children (body mass index [BMI] >85 in growth curves for Centers for Disease Control/National Center for Health Statistics), and the control group of 64 non-obese children (percentile <85), % body fat, platelet activation was assessed by sP-selectin. Other measures were leptin, uric acid (UA), von Willebrand Factor (vWF), plasminogen activator inhibitor (PAI-1), lipid profile, and glucose.
Results:
Obese children displayed higher plasma sP-selectin, leptin, PAI-1, and vWF than non-obese children. In the univariate logistic regression analysis, leptin, vWF, UA, and high density lipoprotein (HDL), but not with PAI-1, were factors associated with platelet activation. By stepwise linear regression analysis adjusted by sex and age, the best predictor variables for platelet activation were leptin (β:0.381; t:4.665; P=0.0001), vWF (β:0.211; t:2.926; P=0.004), UA (β:0.166; t:2.146; P=0.034), and HDL (β:-0.215; t:-2.819; P=0.006).
Conclusions:
Obese children have a higher risk of developing early platelet activation. Factors associated with platelet activation were Leptin, vWF, UA, and HDL. Further studies involving larger numbers of patients over a longer duration are needed to understand the possible molecular mechanism underlying the association between leptin, vWF, and UA and endothelial activation and/or endothelial damage/dysfunction in obese children and its influence in cardiovascular disease in adults.
Related Concept Videos
Obesity
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Drug Dosing: Obese Patients

